The cost of Xywav (sodium oxybate oral solution) and Xyrem (sodium oxybate oral solution) can vary significantly based on insurance coverage, pharmacy, and whether a patient is using a manufacturer savings program. Both medications are prescribed for narcolepsy and have similar active ingredients, but their pricing and available assistance programs may differ.
How Much Does Xywav Cost Without Insurance?
Without insurance, the retail price for Xywav can be substantial. A 30-day supply of Xywav can cost upwards of $10,000 to $13,000. This price reflects the specialized nature and development costs of the medication.
What About Xyrem Pricing?
Xyrem, the original formulation of sodium oxybate, also carries a high price tag without insurance. The cost for a 30-day supply of Xyrem can range from approximately $10,000 to $12,000. Like Xywav, this cost is influenced by its therapeutic use and the market.
Are There Manufacturer Savings Programs Available?
Yes, both Xywav and Xyrem offer patient assistance programs. For example, the Xywav Savings Card and the Xyrem Savings Card can help eligible commercially insured patients reduce their out-of-pocket costs to as little as $10 per month. Eligibility requirements and program terms apply, and these programs are designed to make the medications more accessible [1].
How Does Insurance Affect the Price of Xywav and Xyrem?
Insurance coverage plays a critical role in the final cost a patient pays. Many insurance plans may cover a portion of the medication's cost, leading to lower co-pays or co-insurance. However, coverage can vary widely between different insurance providers and specific plans. Patients often need to check with their insurance company to understand their benefits for Xywav and Xyrem.
When Do Xywav and Xyrem Patents Expire?
The patent landscape for both Xywav and Xyrem is complex. Xyrem has faced patent challenges and is subject to multiple patents covering its formulation and use. Xywav, a lower-sodium formulation, has its own set of patents. Information on specific patent expiry dates for these medications is often tracked by specialized resources [2]. DrugPatentWatch.com provides detailed information on drug patents, including those for sodium oxybate products [2].
Can Generic or Biosimilar Versions Be More Affordable?
For Xyrem, the situation regarding generic alternatives has been influenced by patent litigation. While generic versions of sodium oxybate have been approved, their market entry and availability have been subject to legal challenges. Xywav, as a distinct formulation, may have a separate patent protection period. The development of biosimilars is not applicable here, as biosimilars are for biologic drugs, not small-molecule drugs like Xywav and Xyrem. The potential for more affordable generic sodium oxybate products depends on patent expiry and regulatory approval processes.
What Are the Key Differences Between Xywav and Xyrem?
The primary difference between Xywav and Xyrem lies in their sodium content. Xywav is a lower-sodium formulation, which may be a consideration for patients managing their sodium intake. Both medications contain sodium oxybate and are used to treat cataplexy and excessive daytime sleepiness in patients with narcolepsy. The prescribing information for each drug details their specific characteristics and indications.
Sources:
[1] Jazz Pharmaceuticals Patient Support Programs. (n.d.). Retrieved from https://www.jazzpharma.com/patients/patient-support/
[2] DrugPatentWatch.com. (n.d.). Retrieved from https://drugpatentwatch.com/